JEJade Ebbelaar

Jade Ebbelaar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jade Ebbelaar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Agustin Enciso-Martinez

    Oncode Institute and Department of Cell and Chemical Biology Leiden University Medical Center Leiden The Netherlands

    1 shared publication
  • Ali Salanti

    Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark

    1 shared publication
  • Caroline Løppke

    Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

    1 shared publication
  • Edwin van der Pol

    Amsterdam UMC, University of Amsterdam Biomedical Engineering & Physics, Meibergdreef 9; Cancer Center Amsterdam, Imaging and Biomarkers University of Amsterdam Amsterdam the Netherlands

    1 shared publication
  • Elena Ethel Vidal-Calvo

    Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark

    1 shared publication
  • Emma P. E. M. Boerrigter

    Oncode Institute Department of Cell and Chemical Biology Leiden University Medical Center Leiden the Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour‐Derived Extracellular Vesicles

    by Agustin Enciso‐Martinez, Caroline Løppke, Joyce J. Koene, Jade Ebbelaar, Meike van der Geest, Mandy Los, Emma P. E. M. Boerrigter, Robert Dagil, Tobias Gustavsson, Elena E. Vidal‐Calvo, et al.

    Tumour‐derived extracellular vesicles (tdEVs) are widely studied for their contribution to tumour progression and metastasis. These studies are hampered by the lack of specific markers to identify the tdEVs. Here, we show that oncofoetal chondroitin sulphate, a malignancy‐associated glycosaminoglycan modification, is present on tdEVs and can be targeted by the malaria VAR2CSA protein or C9 antibody. Using a fluorescently labelled recombinant VAR2CSA protein, we identified EVs from cancer cells in vitro by super‐resolution fluorescence microscopy and flow cytometry, as well as in a proof‐of‐concept study using plasma samples from pancreatic adenocarcinoma patients. Thus, the binding of VAR2CSA offers a tool to identify tdEVs, and can be used to explore their function and biomarker potential in cancer.